Annovis Bio Inc (ANVS) — Cash Flow-to-Debt Ratio
Latest as of March 2026:
-0.69x
Annovis Bio Inc (ANVS) has a Cash Flow-to-Debt Ratio of -0.69x as of March 2026, meaning its operating cash flow of $-9.01 Million could theoretically repay -1% of its total liabilities ($13.12 Million) in one year. See Annovis Bio Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.69x
Operating CF / Total Liabilities
Operating Cash Flow
$-9.01 Million
USD
Total Liabilities
$13.12 Million
USD
Data as of
Mar 2026
Most recent filing
Annovis Bio Inc Cash Flow-to-Debt Ratio (2009–2025)
Historical debt coverage capacity for Annovis Bio Inc across 13 annual periods. For the full cash flow conversion analysis, see ANVS cash generation efficiency.
Annual Cash Flow-to-Debt Ratio for Annovis Bio Inc (2009–2025)
Year-by-year debt coverage analysis for Annovis Bio Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -6056.13x | $-25.62 Billion | $4.23 Million | ▼ -27.7% |
| 2024 | -4741.16x | $-21.89 Billion | $4.62 Million | ▼ -212941.6% |
| 2023 | -2.23x | $-39.97 Million | $17.96 Million | ▲ +1.0% |
| 2022 | -2.25x | $-17.31 Million | $7.70 Million | ▲ +62.9% |
| 2021 | -6.06x | $-9.13 Million | $1.51 Million | ▲ +11.7% |
| 2020 | -6.87x | $-3.97 Million | $578.38K | ▼ -13865.2% |
| 2019 | -0.05x | $-476.54K | $9.69 Million | ▲ +32.7% |
| 2018 | -0.07x | $-558.61K | $7.64 Million | ▲ +0.4% |
| 2017 | -0.07x | $-537.48K | $7.32 Million | ▲ +99.1% |
| 2012 | -8.10x | $-1.41 Million | $174.36K | ▼ -1808.1% |
| 2011 | -0.42x | $-3.01 Million | $7.09 Million | ▼ -33.0% |
| 2010 | -0.32x | $-1.77 Million | $5.55 Million | ▲ +96.3% |
| 2009 | -8.56x | $-389.23K | $45.49K | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.